We told you when we posted about it last week (here and here) that the FDA’s new proposed CBE regulation would create a firestorm.
The organization formerly known as ATLA was the first to react, but the Democrats in Congress were not far behind.
Today’s Star-Ledger reported on a letter several leading Democrats have sent to the FDA objecting to the proposed rule.
We haven’t heard the last of this, we promise you, and if you want to read more, there’s a brand new synopsis of the FDA’s proposal at the FDA Law Blog.